COVID-19 Respiratory Infection Clinical Trials

8 recruitingLast updated: June 17, 2026

There are 8 actively recruiting covid-19 respiratory infection clinical trials across 7 countries. Studies span Phase 2, Phase 3, Not Applicable. Top locations include Beijing, Beijing Municipality, China, Berlin, Germany, Brisbane, Queensland, Australia. Updated daily from ClinicalTrials.gov.


COVID-19 Respiratory Infection Trials at a Glance

8 actively recruiting trials for covid-19 respiratory infection are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Beijing, Berlin, and Brisbane. Lead sponsors running covid-19 respiratory infection studies include Chinese University of Hong Kong, KARE Biosciences, and Australian and New Zealand Intensive Care Research Centre.

Browse covid-19 respiratory infection trials by phase

Treatments under study

About COVID-19 Respiratory Infection Clinical Trials

Looking for clinical trials for COVID-19 Respiratory Infection? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new COVID-19 Respiratory Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about COVID-19 Respiratory Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

COVID-19 pneumoniaCOVID-19 Respiratory InfectionCOVID-19+4 more
Weill Medical College of Cornell University510 enrolled3 locationsNCT05164744
Recruiting

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

SARS-CoV-2 virusCOVID-19 pneumoniaCOVID-19 Respiratory Infection+2 more
The Geneva Foundation100 enrolled1 locationNCT06402318
Recruiting

Respiratory Virus Metagenomics After COVID-19

COVID-19 Respiratory Infection
Chinese University of Hong Kong500 enrolled1 locationNCT05126589
Recruiting
Phase 2Phase 3

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

COVID-19 Respiratory Infection
Peking Union Medical College Hospital1,096 enrolled1 locationNCT05689034
Recruiting
Not Applicable

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

COVID-19 Respiratory InfectionPneumoniaMechanical Ventilation Complication+3 more
Australian and New Zealand Intensive Care Research Centre140 enrolled7 locationsNCT05562505
Recruiting

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

COVID-19 Respiratory Infection
University Hospital, Strasbourg, France75 enrolled1 locationNCT06490744
Recruiting

Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients

COVID-19 Respiratory Infection
University Hospital Hradec Kralove30 enrolled1 locationNCT04887623
Recruiting
Phase 2Phase 3

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

COVID-19 pneumoniaCOVID-19 Respiratory Infection
KARE Biosciences324 enrolled7 locationsNCT05706454